Sorry, your browser is not compatible with this application. Please use the latest version of Google Chrome, Mozilla Firefox, Microsoft Edge or Safari.
IT Content
Information Technology
The IRS relies heavily on IT systems to collect trillions in taxes and issue refunds, making modernization a critical mission priority. In FY2024, the agency reported most modernization projects were…
Learn More
Vision for the IC Information Environment: An...
The Intelligence Community (IC) provides the United States and its allies and partners with an unmatched decision advantage over adversaries. As an information-driven enterprise, infrastructure underpins success. The IC relies…
Learn More
Fulcrum: The Department of Defense Information...
The Department’s Fulcrum initiative embodies a bold IT advancement strategy, designed to harness the power of technology for transformative change. By prioritizing user experience, scalability, and cybersecurity, Fulcrum paves the…
Learn More
U.S. Department of Justice Information Technology...
The DOJ IT Strategic Plan for FY 2025–2027 outlines five core goals: enhancing service delivery, elevating cybersecurity, expanding innovation, advancing the workforce, and increasing financial transparency. The plan emphasizes the…
Learn More
Rethinking Antitrust: The Case for Dynamic...
This report explores how dynamic competition shapes innovation, pricing, and market power in the modern economy. Rather than focusing solely on traditional antitrust enforcement, it examines how new entrants, technological…
Learn More
Tip of the Iceberg
Debates about Big Tech often focus on market power and regulation, but this report highlights the far-reaching role these companies play in U.S. innovation, infrastructure, and security. Firms like Amazon,…
Learn More
How Chinese Online Marketplaces Fuel Counterfeits
Chinese e-commerce platforms like Temu, AliExpress, and SHEIN are facilitating the sale of counterfeit goods that threaten U.S. consumers, brands, and intellectual property. The Information Technology and Innovation Foundation (ITIF)…
Learn More
How Digital Services Empower SMEs and Start-Ups
Small and medium-sized enterprises (SMEs) face persistent challenges—limited capital, talent shortages, and lower productivity compared to larger firms. Digital services like AI, cloud computing, and e-commerce platforms are reshaping how…
Learn More
A Time to Act: Policies to Strengthen the US...
Robotics is no longer a future concern—it’s reshaping industries, defense, and the workforce in real time. The 2025 U.S. Robotics Policy outlines how the federal government plans to harness robotics…
Learn More
The Bayh-Dole Act’s Role in Stimulating...
The Bayh-Dole Act helped unlock the economic potential of federally funded research, but its benefits have not reached all communities equally. Today, there’s a growing push to ensure that innovation…
Learn More
AR/VR’s Potential in Health Care
Augmented and virtual reality (AR/VR) technologies are rapidly redefining health care—from personalized surgical planning and chronic pain relief to mental health treatment and medical education. This report outlines how immersive…
Learn More
“Big Pharma” Is a Normal Industry
Despite growing calls from across the political spectrum to impose price controls on prescription drugs, this report argues that many common criticisms of the pharmaceutical industry don’t align with the…
Learn More
Small Modular Reactors: A Realist Approach to the...
Small Modular Reactors (SMRs) offer a promising path forward for nuclear energy—providing clean, reliable, and potentially more affordable power through factory-built, scalable designs. This report outlines how SMRs could serve…
Learn More
Toward Globalization 2.0: A New Trade Policy...
The era of Globalization 1.0, marked by idealistic free trade and fading borders, is giving way to a more grounded strategy that recognizes geopolitical realities and national interests. This new…
Learn More
The Inflation Reduction Act Is Negotiating the...
The Inflation Reduction Act introduced a pricing policy that gives small-molecule drugs only 9 years of market exclusivity—four fewer than their large-molecule counterparts. While aiming to reduce costs, this distinction…
Learn More